PEPTIDELABSign in

GLP-1 / incretin

Semaglutide

Multiple large human RCTs

Approved (Ozempic / Wegovy).

What's actually proven

  • ✓~15% average weight loss at 2.4 mg weekly over 68 weeks (STEP-1).
  • ✓Reduced major cardiovascular events by 20% in people with obesity and heart disease (SELECT).

The bullshit / overstated

  • ✗"You'll keep the weight off" — most people regain about two-thirds within a year of stopping.
  • ✗Compounded/research versions are not the same product as Wegovy.

Side effects

  • •Nausea, vomiting, diarrhoea, constipation
  • •Gallstones
  • •Muscle loss without resistance training

Don't use if

  • !Medullary thyroid cancer / MEN2 history
  • !Pancreatitis history
  • !Pregnancy

Typical protocol (from clinical trials)

Once weekly